2012 - 2016 重庆医科大学 获学士学位
2016 - 2022 电子科技大学 获博士学位
2022 - 至今 郑州大学 助理研究员
（1）纳米酶设计与构建及其生物医学应用
（2）致盲眼病纳米酶抗氧化治疗研究
1.Bai Xue; Mengyue Ge; Kelong Fan; Xinglu Huang; Xiyun Yan; Wei Jiang; Bing Jiang; Zhenglin Yang; Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease,Journal of Controlled Release, 2022, 350: 271-283.
2. Ruofei Zhang#;Bai Xue#; Yanhong Tao#; Hanqing Zhao; Zixia Zhang; Xiaonan Wang; Xinyao Zhou; Bing Jiang; Zhenglin Yang; Xiyun Yan; Kelong Fan ; Edge‐Site Engineering of Defective Fe–N 4 Nanozymes with Boosted Catalase‐Like Performance for Retinal Vasculopathies,Advanced Materials, 2022, 34(39): 2270275.
3.Bai Xue; Ping Wang; Wenzhen Yu; Jing Feng; Jie Li; Rulian Zhao; Zhenglin Yang; Xiyun Yan; Hongxia Duan; CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases,Science China Life Sciences, 2021, 65(6): 1157-1170.
4.Bai Xue; Shanshan Zhang; Li Gan; Weifeng Lu; Jie Li; A new hand-held holder optimizes the parameters of the laser-induced choroidal neovascularization model in mice,Experimental Eye Research, 2021, 203: 108392.
5. Jialiang Yang; Yuhong Chen; Tongdan Zou;Bai Xue; Fang Yang; Xiangzhou Wang; Yibo Huo; Boyun Yan; Yuxia Xu; Shiyu He; Yi Yin; Jing Wang; Xiong Zhu; Lin Zhang; Yu Zhou; Zhengfu Tai; Ping Shuai; Man Yu; Qian Luo; Yilian Cheng; Bo Gong; Xianjun Zhu; Jing Zhang; Xinghuai Sun; YingLin; Houbin Zhang; Zhenglin Yang ; Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival,Science China Life Sciences, 2022, 66(2): 211-225.
薛白 助理研究员
研究方向：纳米酶生物医学应用研究
电子邮件：xuebai2022@zzu.edu.cn
电 话：
通讯地址：河南省郑州市科学大道100号郑州大学新校区
英文版个人网页：